Novel anti cxcr4 antibodies and their use for the treatment...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01)

Patent

CA 2738782

The present invention relates to a novel isolated antibody, or the derived compounds or functional fragments of same, capable of binding to CXCR4 but also of inducing conformational changed of the CXCR4 homodimers and/or heterodimers. More particularly, the present invention relates to the 414H5 and 515H7 antibodies, specific to the CXCR4 protein, as well as their use for the treatment of cancer. Pharmaceutical compositions composed of such antibodies and a process for the selection of such antibodies are also covered.

La présente invention concerne un nouvel anticorps isolé, ou les composés dérivés ou des fragments fonctionnels de celui-ci, capables de se lier à CXCR4 mais également dinduire des changements de conformation des homodimères et/ou hétérodimères de CXCR4. Plus particulièrement, la présente invention concerne les anticorps 414H5 et 515H7, spécifiques de la protéine CXCR4, ainsi que leur utilisation pour le traitement du cancer. La présente invention concerne en outre des compositions pharmaceutiques contenant de tels anticorps et un procédé pour la sélection de tels anticorps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel anti cxcr4 antibodies and their use for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel anti cxcr4 antibodies and their use for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel anti cxcr4 antibodies and their use for the treatment... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1351299

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.